Clinical Trial Update: Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC [NA]

View source ↗

Summary

Clinical trial update on a pilot study for resectable esophageal adenocarcinoma examining the relevance of circulating tumor cells.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma

Snippet

Sponsor: University Hospital Freiburg | Conditions: Esophageal Adenocarcinoma | NA | Status: COMPLETED